Envista Holdings Corporation (NYSE:NVST) Given Consensus Recommendation of “Hold” by Analysts

Envista Holdings Corporation (NYSE:NVST) has earned a consensus rating of “Hold” from the fifteen analysts that are covering the company, Marketbeat reports. Nine research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $28.8333.

Several research analysts have issued reports on NVST shares. Zacks Research lowered Envista from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Robert W. Baird boosted their price target on Envista from $30.00 to $31.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Weiss Ratings lowered Envista from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Citigroup began coverage on Envista in a report on Wednesday, April 15th. They issued a “neutral” rating and a $29.00 price target for the company. Finally, Mizuho boosted their price target on Envista from $24.00 to $27.00 and gave the company a “neutral” rating in a report on Tuesday, February 10th.

Envista Trading Down 0.1%

Shares of NYSE NVST opened at $23.08 on Monday. The business’s 50 day moving average is $25.13 and its two-hundred day moving average is $24.58. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.44 and a quick ratio of 2.06. Envista has a 1-year low of $18.25 and a 1-year high of $30.42. The stock has a market capitalization of $3.76 billion, a P/E ratio of 56.29, a PEG ratio of 1.31 and a beta of 0.88.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.05. Envista had a return on equity of 7.11% and a net margin of 2.41%.The company had revenue of $705.50 million for the quarter, compared to analysts’ expectations of $680.04 million. During the same period in the previous year, the firm posted $0.24 earnings per share. The firm’s revenue for the quarter was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, research analysts expect that Envista will post 1.42 EPS for the current year.

Institutional Trading of Envista

A number of large investors have recently modified their holdings of NVST. Caitong International Asset Management Co. Ltd raised its stake in Envista by 16,711.1% in the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after buying an additional 1,504 shares in the last quarter. Allworth Financial LP raised its stake in Envista by 75.4% in the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock worth $39,000 after buying an additional 776 shares in the last quarter. UMB Bank n.a. raised its stake in Envista by 46.1% in the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after buying an additional 636 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Envista by 73.1% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after buying an additional 949 shares in the last quarter. Finally, IFP Advisors Inc raised its stake in Envista by 102.9% in the fourth quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock worth $46,000 after buying an additional 1,071 shares in the last quarter.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.